Stockreport

Biodesix Announces Third Quarter 2025 Results and Highlights

Biodesix, Inc.  (BDSX) 
PDF Q3 2025 Revenue of $21.8 million, an increase of 20% over Q3 2024; Q3 2025 gross profit margin of 81%, a 400-basis point improvement from Q3 2024; Raised FY2025 Total [Read more]